RNG vs. MEDP, HQY, BILI, WPP, LYFT, ETSY, AMTM, MARA, WSC, and SEZL
Should you be buying Ringcentral stock or one of its competitors? The main competitors of Ringcentral include Medpace (MEDP), HealthEquity (HQY), Bilibili (BILI), WPP (WPP), Lyft (LYFT), Etsy (ETSY), Amentum (AMTM), Marathon Digital (MARA), WillScot (WSC), and Sezzle (SEZL). These companies are all part of the "business services" industry.
Ringcentral vs. Its Competitors
Medpace (NASDAQ:MEDP) and Ringcentral (NYSE:RNG) are both mid-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.
Medpace has a net margin of 19.31% compared to Ringcentral's net margin of -1.65%. Medpace's return on equity of 54.36% beat Ringcentral's return on equity.
Medpace has higher earnings, but lower revenue than Ringcentral. Ringcentral is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.
Medpace has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500. Comparatively, Ringcentral has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500.
78.0% of Medpace shares are owned by institutional investors. Comparatively, 98.6% of Ringcentral shares are owned by institutional investors. 20.3% of Medpace shares are owned by insiders. Comparatively, 7.0% of Ringcentral shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Medpace presently has a consensus price target of $344.82, suggesting a potential upside of 7.25%. Ringcentral has a consensus price target of $33.08, suggesting a potential upside of 10.53%. Given Ringcentral's stronger consensus rating and higher probable upside, analysts plainly believe Ringcentral is more favorable than Medpace.
In the previous week, Ringcentral had 3 more articles in the media than Medpace. MarketBeat recorded 9 mentions for Ringcentral and 6 mentions for Medpace. Medpace's average media sentiment score of 0.73 beat Ringcentral's score of 0.60 indicating that Medpace is being referred to more favorably in the media.
Summary
Medpace beats Ringcentral on 10 of the 16 factors compared between the two stocks.
Get Ringcentral News Delivered to You Automatically
Sign up to receive the latest news and ratings for RNG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RNG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ringcentral Competitors List
Related Companies and Tools
This page (NYSE:RNG) was last updated on 7/3/2025 by MarketBeat.com Staff
